Alemtuzumab, Fludarabine, Low-Dose TBI, and Double Umbilical Cord Transplant for Primary Graft Failure in a Patient with Recurrent HLH.

Hege, Kerry; Quigg, Troy; Delgado, David

Hege, Kerry; Quigg, Troy; Delgado, David.

Affiliation

Hege K; Section of Pediatric Hematology/Oncology, Department of Pediatrics, Riley Hospital for Children at Indiana University Health, Indiana University School of Medicine, Indianapolis, Indiana.
Quigg T; Pediatric Blood and Marrow Transplantation Program, San Antonio, Texas.
Delgado D; Section of Pediatric Hematology/Oncology, Department of Pediatrics, Riley Hospital for Children at Indiana University Health, Indiana University School of Medicine, Indianapolis, Indiana.

Pediatr Blood Cancer ; 63(2): 361-3, 2016 Feb.

Article in En | MEDLINE | ID: mdl-26488531

Subject(s)

Cord Blood Stem Cell Transplantation/methods; Lymphohistiocytosis, Hemophagocytic/therapy; Salvage Therapy/methods; Transplantation Conditioning/methods; Alemtuzumab; Antibodies, Monoclonal, Humanized/administration & dosage; Combined Modality Therapy; Graft vs Host Disease; Humans; Infant; Male; Recurrence; Vidarabine/administration & dosage; Vidarabine/analogs & derivatives; Whole-Body Irradiation/methods

Key words

engraftment failure; hematopoietic stem cell transplantation; hemophagocytic lymphohistiocytosis; pediatric

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salvage Therapy / Transplantation Conditioning / Cord Blood Stem Cell Transplantation / Lymphohistiocytosis, Hemophagocytic Limits: Humans / Infant / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2016 Type: Article

Fulltext

XML

PubMed Links

Search on Google